Collectively, TRAF3IP2 acts as an activator of the NOTCH1 signaling pathway to mediate the progression of NONO-TFE3 tRCC. The gene discussed is NOTCH1; the disease is renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.